Death Ligand TRAIL Induces No Apoptosis but Inhibits Activation of Human (Auto)antigen-Specific T Cells
Abstract TNF-related apoptosis-inducing ligand (TRAIL), a member of the TNF superfamily, induces apoptosis in susceptible cells, which can be both malignant and nontransformed. Despite homologies among the death ligands, there are great differences between the TRAIL system on the one hand and the TN...
Gespeichert in:
Hauptverfasser: | Jan D. Lünemann, Sonia Waiczies, Stefan Ehrlich, Uwe Wendling, Bibiane Seeger, Thomas Kamradt, Frauke Zipp |
---|---|
Format: | Artigo |
Sprache: | Englisch |
Veröffentlicht: |
2002
|
Online-Zugang: | https://doi.org/10.4049/jimmunol.168.10.4881 https://journals.aai.org/jimmunol/article-pdf/168/10/4881/1314023/4881.pdf |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Ähnliche Einträge
Ähnliche Einträge
-
Neuronal Damage in Autoimmune Neuroinflammation Mediated by the Death Ligand TRAIL
von: Orhan Aktaş, et al.
Veröffentlicht: (2005) -
Treatment of Relapsing Paralysis in Experimental Encephalomyelitis by Targeting Th1 Cells through Atorvastatin
von: Aktas, Orhan, et al.
Veröffentlicht: (2003) -
Lack of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand But Presence of Its Receptors in the Human Brain
von: Dörr, Jan, et al.
Veröffentlicht: (2002) -
Treatment of Relapsing Paralysis in Experimental Encephalomyelitis by Targeting Th1 Cells through Atorvastatin
von: Orhan Aktaş, et al.
Veröffentlicht: (2003) -
Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2
von: Uwe Bertsch, et al.
Veröffentlicht: (2014)